Yahoo
    OTC Markets OTCQX - Delayed Quote USD

    Curaleaf Holdings, Inc. (CURLF)

    Is CURLF a long-term buy?
    9.64 +0.10 (+1.05%)
    As of 12:07:40 PM EDT. Market Open.
    Is CURLF a long-term buy?
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for CURLF
    • Previous Close 9.54
    • Open 9.65
    • Bid 9.61 x 79700
    • Ask 9.65 x 1000000
    • Day's Range 9.50 - 9.65
    • 52 Week Range 5.40 - 15.15
    • Volume 4,969
    • Avg. Volume 199,230
    • Market Cap (intraday) 2.553B
    • Beta (5Y Monthly) 1.64
    • PE Ratio (TTM) --
    • EPS (TTM) -0.16
    • Earnings Date (est.) Nov 4, 2026
    • Forward Dividend & Yield --
    • Ex-Dividend Date --
    • 1y Target Est 15.00

    Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

    www.curaleaf.com

    5,554

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Curaleaf Holdings, Inc.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

    YTD Return

    CURLF
    25.03%
    S&P/TSX Composite index (^GSPTSE)
    14.95%

    1-Year Return

    CURLF
    14.76%
    S&P/TSX Composite index (^GSPTSE)
    26.68%

    3-Year Return

    CURLF
    16.32%
    S&P/TSX Composite index (^GSPTSE)
    78.29%

    5-Year Return

    CURLF
    73.42%
    S&P/TSX Composite index (^GSPTSE)
    75.93%

    Earnings Trends

    View More

    Earnings Per Share

    GAAP
    Normalized
    GAAP
    Normalized

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q2 FY26
    Revenue 340.1M
    Earnings 12.51M
    Profit Margin 3.68%

    Q3

    FY25

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    -100M
    0
    100M
    200M
    300M
    -30.0%
    -20.0%
    -10.0%
    0.0%
    10.0%
    20.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    15.00
    15.00 Average
    9.64 Current
    15.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell

    Latest Rating

    Date 8/8/2024
    Analyst Needham
    Rating Action Reiterates
    Rating Buy
    Price Action Maintains
    Price Target 6.25 -> 6.25
    View More

    Statistics

    View More

    Valuation Measures

    Annual
    As of 9/2/2026

    • Market Cap

      2.64B

    • Enterprise Value

      3.45B

    • Trailing P/E

      --

    • Forward P/E

      --

    • PEG Ratio (5yr expected)

      --

    • Price/Sales (ttm)

      2.01

    • Price/Book (mrq)

      2.99

    • Enterprise Value/Revenue

      2.60

    • Enterprise Value/EBITDA

      15.76

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -2.63%

    • Return on Assets (ttm)

      0.32%

    • Return on Equity (ttm)

      -2.35%

    • Revenue (ttm)

      1.32B

    • Net Income Avi to Common (ttm)

      -41.2M

    • Diluted EPS (ttm)

      -0.16

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      94.59M

    • Total Debt/Equity (mrq)

      128.51%

    • Levered Free Cash Flow (ttm)

      103.06M

    View More

    Compare

    Compare

    Select to analyze similar companies using key performance metrics; select up to 4 stocks.

    CURLF
    Curaleaf Holdings, Inc.
    9.64
    +1.05%
    Mkt Cap 2.553B
    Industry Drug Manufacturers—Specialty & Generic
    TCNNF
    Trulieve Cannabis Corp.
    8.84
    -0.56%
    Mkt Cap 1.7B
    Industry Drug Manufacturers—Specialty & Generic
    GTBIF
    Green Thumb Industries Inc.
    7.48
    -0.13%
    Mkt Cap 1.635B
    Industry Drug Manufacturers—Specialty & Generic
    CRLBF
    Cresco Labs Inc.
    0.7600
    +2.56%
    Mkt Cap 282.985M
    Industry Drug Manufacturers—Specialty & Generic
    VRNO
    Verano Holdings Corp.
    6.00
    +0.50%
    Mkt Cap 439.308M
    Industry Drug Manufacturers—Specialty & Generic
    CRON
    Cronos Group Inc.
    3.2650
    +0.15%
    Mkt Cap 1.203B
    Industry Drug Manufacturers—Specialty & Generic
    OGI
    Organigram Global Inc.
    1.1550
    -1.29%
    Mkt Cap 162.862M
    Industry Drug Manufacturers—Specialty & Generic
    CGC
    Canopy Growth Corporation
    0.9730
    +0.01%
    Mkt Cap 462.72M
    Industry Drug Manufacturers—Specialty & Generic
    ACB
    Aurora Cannabis Inc.
    3.9586
    +1.76%
    Mkt Cap 250.619M
    Industry Drug Manufacturers—Specialty & Generic
    TLRY
    Tilray Brands, Inc.
    4.5199
    -0.22%
    Mkt Cap 621.852M
    Industry Drug Manufacturers—Specialty & Generic
    TSNDF
    TerrAscend Corp.
    0.6500
    +1.56%
    Mkt Cap 242.234M
    Industry Drug Manufacturers—Specialty & Generic

    People Also Watch

    VRNO Verano Holdings Corp.
    6.00 +0.50%
    GLAS Glass House Brands Inc.
    8.78 +2.09%
    TSNDF TerrAscend Corp.
    0.6500 +1.56%
    CURA.TO Curaleaf Holdings, Inc.
    13.45 +2.05%
    VREOF Vireo Growth Inc.
    11.10 +2.40%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: